Pharmaceutical Executive
July 01, 2008
Leadership
0
0
Rejection is tough to take, but leaders have the drive and ability to bounce back from a setback with boundless energy
July 01, 2008
From the Editor
0
0
It's not that I disagree with the Obama and McCain healthcare proposals. It's that there's nothing actually there to disagree with
July 01, 2008
Washington Report
0
0
Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary
July 01, 2008
Thought Leader
0
0
Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second
July 01, 2008
Columns
0
0
An innovative approach bridges the pediatric communication gap
July 01, 2008
Features
0
0
A look at some of the court cases that could actually change the pharma playing field
July 01, 2008
Columns
0
0
A strict marketing regimen will help keep your brand healthy in the digital
July 01, 2008
Features
0
0
Could gene silencing be the next great innovation in drug development? Some biotechs are betting on it.
July 01, 2008
Back Page
0
0
No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics